Sound Income Strategies’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.15K | Hold |
147
| – | – | ﹤0.01% | 1016 |
|
|
2025
Q1 | $5K | Buy |
147
+20
| +16% | +$681 | ﹤0.01% | 1060 |
|
|
2024
Q4 | $5K | Hold |
127
| – | – | ﹤0.01% | 981 |
|
|
2024
Q3 | $5.97K | Hold |
127
| – | – | ﹤0.01% | 916 |
|
|
2024
Q2 | $6.86K | Hold |
127
| – | – | ﹤0.01% | 859 |
|
|
2024
Q1 | $8.66K | Sell |
127
-5
| -4% | -$341 | ﹤0.01% | 796 |
|
|
2023
Q4 | $8.26K | Buy |
132
+5
| +4% | +$313 | ﹤0.01% | 781 |
|
|
2023
Q3 | $5.77K | Hold |
127
| – | – | ﹤0.01% | 721 |
|
|
2023
Q2 | $7.13K | Hold |
127
| – | – | ﹤0.01% | 657 |
|
|
2023
Q1 | $5.74K | Hold |
127
| – | – | ﹤0.01% | 679 |
|
|
2022
Q4 | $5.16K | Hold |
127
| – | – | ﹤0.01% | 644 |
|
|
2022
Q3 | $8K | Hold |
127
| – | – | ﹤0.01% | 499 |
|
|
2022
Q2 | $8K | Hold |
127
| – | – | ﹤0.01% | 501 |
|
|
2022
Q1 | $8K | Sell |
127
-331
| -72% | -$20.9K | ﹤0.01% | 510 |
|
|
2021
Q4 | $35K | Sell |
458
-16
| -3% | -$1.22K | ﹤0.01% | 281 |
|
|
2021
Q3 | $53K | Hold |
474
| – | – | 0.01% | 220 |
|
|
2021
Q2 | $77K | Buy |
474
+347
| +273% | +$56.4K | 0.01% | 194 |
|
|
2021
Q1 | $15.5K | Buy |
+127
| New | +$15.5K | ﹤0.01% | 398 |
|